TBT: Fabimycin: an antibiotic candidate

Originally published on October 13, 2022, this episode features Luis in conversation with Dr. Paul Hergenrother from the University of Illinois. Dr. Hergenrother discusses Fabimycin, an antibiotic candidate targeting gram-negative bacteria. What is Fabimycin’s mechanism of action? Which bacteria is it active against? Is there any intrinsic resistance? Tune in to find out!

Link to article: https://pubs.acs.org/doi/10.1021/acscentsci.2c00598

Questions? Feedback? Send those to [email protected]

Want to support the podcast? Here's how:

Venmo: https://venmo.com/u/letstalkmicro

Buy me a Ko-fi: https://ko-fi.com/letstalkmicro